“Public Health Experts”: Poor at Risk of Being Left Behind as Rich Buy Up New Covid Drug

Source: Common Dreams

“Public health experts are voicing increased concern that poor countries (already denied adequate access to coronavirus vaccines) could be left behind once again as rich nations rush to buy up supplies of Merck’s promising new Covid-19 drug before it has even won regulatory approval. ‘Have we learned our lesson?’ Rachel Cohen, North America regional executive director for the nonprofit group Drugs for Neglected Diseases Initiative, asked in an interview with Bloomberg on Tuesday. ‘The majority of people in low- and middle-income countries haven’t been vaccinated and could potentially benefit tremendously from this treatment if they got it early enough.’ The treatment in question is known as molnupiravir, an antiviral pill that (according to late-stage clinical trial results that have not yet been peer-reviewed) cut in half the risk of hospitalization or death in patients with mild to moderate cases of Covid-19.” (10/12/21)